Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018

Los Angeles, CA, November 27, 2018 –(PRWirePro.com)– Medifocus, Inc. (OTCQB:MDFZF) and (TSX-V:MFS) (“Medifocus” or the “Company”), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, reported a 26% increase in revenue for the quarter ending September Read more…

Bank7 Corp. Announces 3Q 2018 Earnings

Oklahoma City, OK, October 30, 2018 –(PRWirePro.com)– Bank7 Corp. (NASDAQ:BSVN) (“the Company”), the parent company of Oklahoma City-based Bank7 (the “Bank”), today reported unaudited results for the three and nine months ended September 30, 2018. “We are pleased to have successfully completed our IPO and to announce our 3Q results. Read more…